Patanjali Misleading Medicine Ads Case: Next Date Of Hearing On January 15

New Delhi: The Supreme Court heard on December 13 the plea of the Indian Medical Association (IMA) regarding misleading claims and advertisements against “Allopathic” medicine.

A Bench comprising Justice Abhay Oka and Justice Pankaj Mithal asked amicus Curia Shadhan Farast to give a brief note on the issues involved in the case, details of orders passed so far and compliances made to these orders. The next date of hearing ws set for January 15.

Since it is a new bench, the judges want to understand the matter, the bench said.

The case pertains to a petition filed by the Indian Medical Association seeking action against Patanjali for allegedly conducting a smear campaign against modern medicine and the Covid-19 vaccination drive.

The top court had taken action against Patanjali and the Ramdev-Balkrishna duo for disobeying its orders and asked it to publish advertisements in newspapers apologising for the same. At the same time, it also pulled up certain doctors practising modern medicine.

Related Posts

Gene Therapy for Cholesterol: Initial Test Results Cheer

Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states